EQS-Ad hoc: LifeWatch AG

EQS Group-Ad-hoc: LifeWatch AG / Key word(s): AGM/EGM LifeWatch AG: LifeWatch publishes Annual General Meeting Invitation

24.03.2016 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

LifeWatch publishes Annual General Meeting Invitation

Zug/Switzerland, March 24, 2016 - LifeWatch AG (SIX Swiss Exchange: LIFE), a leading developer and provider of medical solutions and remote diagnostic monitoring services to the digital health market, announces that it has today published the invitation to its annual general meeting.

The board is recommending in the invitation that shareholders authorize an ordinary capital increase of up to 5,000,000 shares in order to combat the potential liquidity shortfall caused by the Highmark award as well as provide resources for future growth and expansion.

Furthermore, the board is also recommending three new board members, which together with the two standing for re-election would mean that the board would consist of five members in the future. Below you will find a short summary on the three board candidates:

Raymond W. Cohen, a citizen of the Unites States of America, a proven leader, board member, entrepreneur, team-builder and creator of shareholder value with more than 30 years of private and public company experience. Accredited public company director and currently CEO of Axonics Modulation Technologies, Irvine, CA, U.S.A.

Dr. Didier Hoch, M.D., a French citizen, a seasoned former senior executive with more than 25 years' experience in the European and Near Middle Eastern pharmaceutical industry. Currently Chairman of Biovision and CEO of Big Booster, an international accelerator for start-ups.

John Doulis, M.B., B.S., Grad Dip Health Inf., an Australian citizen, permanent US resident. A physician executive with post-graduate training in health informatics. Currently Chief Informatics and Information Officer, MedCare Investment Funds; President and Chief Executive Officer of Artemis Healthcare Group and Adjunct Professor of Management, Vanderbilt University Owen Graduate School of Management.

For more information about the annual general meeting please consult the invitation, which is available on the company's website at http://www.irlifewatch.com/lifewatch_ir/pdf/agmandeogm/GV_Einladung_LifeWa tch_210316_EN.pdf

For further questions:

LifeWatch AG c/o Dynamics Group, Philippe Blangey / Doris Rudischhauser Phone: +41 43 268 32 35 / +41 79 410 81 88 E-mail: investor-relations@lifewatch.com

About LifeWatch AG

LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE), Switzerland, is a leading healthcare technology and solutions' company, specializing in advanced digital health systems and wireless remote diagnostic patient monitoring services. LifeWatch's services provide physicians with critical information to determine appropriate treatment and thereby improve patient outcomes. LifeWatch AG has operative subsidiaries in the United States, in Switzerland and in Israel, and is the parent company of LifeWatch Services Inc., and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a leading U.S.-based provider of cardiac monitoring services and home sleep testing of Obstructive Sleep Apnea (OSA). LifeWatch Technologies Ltd., based in Israel, is a leading developer and manufacturer of telemedicine products. For additional information, please visit www.lifewatch.com.

Sign up for customized e-mail alerts and documentation requests at http://www.irlifewatch.com/alert-service.aspx

This press release includes forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding future results of operations and financial position, the business strategy, and plans and objectives for future operations, are forward-looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect" and similar expressions are intended to identify forward-looking statements. LifeWatch AG has based these forward-looking statements largely on current expectations and projections about future events and financial trends that it believes may affect the financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances described may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. All forward-looking statements are based only on data available to LifeWatch AG at the time of the issue of this press release. LifeWatch AG does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS OF THE ISSUER.

End of ad hoc announcement

+++++ Additional features:

Document: http://n.eqs.com/c/fncls.ssp?u=XJYFIRUQPL Document title: LifeWatch publishes Annual General Meeting Invitation

---------------------------------------------------------------------------

24.03.2016 News transmitted by EQS Schweiz AG. www.eqs.com - news archive: http://switzerland.eqs.com/de/News

The issuer is responsible for the contents of the release.

---------------------------------------------------------------------------

Language: English Company: LifeWatch AG Baarerstrasse 139 6300 Zug Switzerland Phone: +41 41 728 67 78 Internet: www.lifewatch.com ISIN: CH0012815459 Valor: 811189 Listed: Regulated Unofficial Market in Berlin, Stuttgart; Open Market in Frankfurt ; SIX End of News EQS Group News Service ---------------------------------------------------------------------------

448531 24.03.2016